Table 2 NACT regimens of patients evaluated
Agents | Dosages | Cycles | No. of patients |
|---|---|---|---|
Fluorouracil + doxorubicin + cyclophosphamide (FAC) Cisplatin + doxorubicin | 500 mg/m2 + 50 mg/m2 + 500 mg/m2 70 mg/m2 + 55 mg/m2 | 3 3 | 1 |
Cisplatin + doxorubicin Docetaxel | 60 mg/m2 + 60 mg/m2 75 mg/m2 | 3 2 | 1 |
Cisplatin + doxorubicin | 50 mg/m2 + 50 mg/m2 | 6 | 3 |
75 mg/m2 + 50 mg/m2 | 5 | 1 | |
60 mg/m2 + 60 mg/m2 | 6 | 2 | |
60 mg/m2 + 60 mg/m2 | 4 | 1 | |
75 mg/m2 + 50 mg/m2 | 4 | 1 | |
50 mg/m2 + 60 mg/m2 | 6 | 1 | |
Carboplatin + docetaxel | AUC-5 + 60 mg/m2 | 6 | 1 |